08/09/2026
A multicenter study of 1,717 biopsy-proven benign breast lesions showed 99.77% complete non-enhancement on day-1 contrast-enhanced ultrasound, with durable lesion regression over a median 38.7-month follow-up.
📌 Complications were minor and self-limiting, with 92.4% of patients reporting excellent cosmetic satisfaction
https://link.springer.com/article/10.1186/s13244-026-02361-x (Ying Zhou et al.)